bullish
Last Week in GER Research: API/Sigma, M1, Eclipx/Mcmillan and Hansoh IPO
517 Views17 Feb 2019 22:54
In this version of the GER weekly research wrap, we assess the bump prospects in the Australian Pharma Industries (API AU) / Sigma Healthcare (SIG...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »- Sigma Healthcare (SIG AU): Next Round of Passive Buying Around the Corner
- S&P/ASX Index Rebalance (Mar 2025): SIG Is the BIG One; Changes Galore Across Indices
- Quiddity ASX Mar25 Results: Multiple Surprises; High Short Buildup for DELs; Rare Successful Trade
- Quiddity Leaderboard ASX Mar 25: Final Expectations; Momentum Still Intact
- MV Australia Equal Weight Index Rebalance Preview: Potential Changes in March; Multiple Overlaps
Trending Collections
More »Trending Insights
More »- Hang Seng Indexes: ADR Depositary Holding Changes; Round-Trip Trade Is US$5.1bn; NetEase Outperforms
- Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Last-Minute Methodology Changes; Final Expectations
- HEM: Dovish Prices Deranged
- MongoDB (MDB US): Fast-Exit from Nasdaq100 in May 2025
- Rare Arb Opportunity from ATS Breakout in Korea: Day-Night Spread
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Last Week in GER Research: API/Sigma, M1, Eclipx/Mcmillan and Hansoh IPO17 Feb 2019
- M1 Ltd (M1 SP): Axiata Throws in the Towel, Delisting Looms17 Feb 2019
- Hansoh Pharma IPO Preview: A Decent Story Tarnished by a Huge Pre-IPO Dividend11 Feb 2019
- API/Sigma Merger: Sigma’s Hand Strengthens to Improve the Terms of API’s Bid11 Feb 2019
x